Drug & medication recalls Moderate risk

Nature-Throid recalled over manufacturing violations

Recall date
August 25, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 66.5 mcg], 1.75 Grain (113.75 mg) Tablet…
Recall number
D-1601-2020
FDA classification
Class II
Brand / firm
RLC Labs Inc.
Sold / distributed
Nationwide in the United States

Why it was recalled

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Nature-Throid, Thyroid USP [liothyronine (T3) 15.75 mcg and levothyroxine (T4) 66.5 mcg], 1.75 Grain (113.75 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3307-4; b) 60-count bottles, NDC 64727-3307-5; c) 90-count bottles, NDC 64727-3307-6; d) 100-count bottles, NDC 64727-3307-1; and e) 1,000-count bottles, NDC 64727-3307-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.

Get recall alerts

Free email alert whenever RLC Labs Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: RLC Labs Inc.